Literature DB >> 11708412

Radiographic damage in rheumatoid arthritis correlates with functional disability but not direct medical costs.

A E Clarke1, Y St-Pierre, L Joseph, J Penrod, J T Sibley, M Haga, H K Genant.   

Abstract

OBJECTIVE: Few longitudinal data exist on the relationship between radiographic damage and self-reported functional disability and direct medical costs in rheumatoid arthritis (RA). We assessed these relationships.
METHODS: One hundred thirty patients with RA (at time of the first available radiograph, mean age 56.6 yrs, 16.9% male, mean disease duration 16.8 yrs) were followed for up to 13.4 years. Semiannually, they reported on functional disability (0 = no difficulty, 3 = unable to do), global severity (0 = very well, 100 = very poor), pain (0 = no pain, 3 = severe pain), and health services utilization through completion of the Stanford Health Assessment Questionnaire (HAQ). Concurrent hand radiographs were scored for erosions and joint space narrowing using the Genant method and a single score summing both erosions and joint space narrowing for both hands was calculated (0 = no damage, 200 = maximum damage). The univariate association of functional disability, global severity, pain, or direct medical costs with concurrent radiographic damage was assessed through Spearman correlations and hierarchical regression models. The hierarchical models permit exploitation of the between-patient and within-patient variation present in our longitudinal data.
RESULTS: At the time of the first available radiograph, mean (SD) levels of functional disability, global severity, and pain were 1.3 (0.7), 39.4 (21.0), and 1.1 (0.7), respectively. At entry into the study, the average radiograph score was 49.7 and upon leaving the study it was 66.9. Patients were followed an average of 6.7 years, with radiograph scores increasing at an average rate of 2.5 units/yr. The Spearman correlation [95% confidence interval (CI)] between average per-patient radiograph score and average per-patient HAQ disability index, average per-patient global severity, average per-patient pain score, and average per-patient direct medical costs was, respectively, 0.42 (0.26, 0.55), 0.23 (0.06, 0.39), 0.20 (0.03, 0.36), and 0.06 (-0.11, 0.23). The mean slope (95% CI) for disability on radiograph score was 0.0186 (0.0132, 0.0226), for severity on radiographs 0.1889 (0.1295, 0.2498), and for pain on radiographs 0.0057 (0.0027, 0.0084). As an example, over 10 years, a 25 unit (i.e., 50%) increase in radiograph scores would, on average, be associated with a 0.46 unit (i.e., 35%) increase in disability, a 4.72 unit (12%) increase in global severity score, and a 0.14 unit (13%) increase in pain, all expressed on the HAQ scales. There was little association between radiograph score and direct medical costs.
CONCLUSION: A clinically meaningful association exists between radiographic damage and self-reported functional disability, suggesting that interventions that slow radiographic progression may improve the patient's health status. Such a relationship was not observed between radiographic damage and direct medical costs.

Entities:  

Mesh:

Year:  2001        PMID: 11708412

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  16 in total

1.  Association between baseline radiographic damage and improvement in physical function after treatment of patients with rheumatoid arthritis.

Authors:  F C Breedveld; C Han; M Bala; D van der Heijde; D Baker; A F Kavanaugh; R N Maini; P E Lipsky
Journal:  Ann Rheum Dis       Date:  2004-07-29       Impact factor: 19.103

2.  MRI of the wrist in early rheumatoid arthritis.

Authors:  C G Peterfy
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

3.  Association of circulating adiponectin levels with progression of radiographic joint destruction in rheumatoid arthritis.

Authors:  Jon T Giles; Desiree M van der Heijde; Joan M Bathon
Journal:  Ann Rheum Dis       Date:  2011-05-13       Impact factor: 19.103

4.  Dickkopf 1 protein circulating levels as a possible biomarker of functional disability and chronic damage in patients with rheumatoid arthritis.

Authors:  Ana M Santos; Eugenia-Lucía Saldarriaga; Rodrigo Giraldo-Bustos; Jesus Giovanny Ballesteros-Muñoz; Juan C Rueda; Francy-Milena Cuervo; José-Ignacio Angarita; Andrés Y Vásquez; Sofía Arias-Correal; Camilo A González; Pedro Santos-Moreno; John Londono
Journal:  Clin Rheumatol       Date:  2017-12-27       Impact factor: 2.980

5.  Disease activity, handgrip strengths, and hand dexterity in patients with rheumatoid arthritis.

Authors:  D Palamar; G Er; R Terlemez; I Ustun; G Can; M Saridogan
Journal:  Clin Rheumatol       Date:  2017-07-18       Impact factor: 2.980

6.  Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis.

Authors:  Jon T Giles; Matthew Allison; Clifton O Bingham; William M Scott; Joan M Bathon
Journal:  Arthritis Rheum       Date:  2009-09-15

Review 7.  Infliximab: a pharmacoeconomic review of its use in rheumatoid arthritis.

Authors:  Katherine A Lyseng-Williamson; Rachel H Foster
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

8.  Pain and joint mobility explain individual subdimensions of the health assessment questionnaire (HAQ) disability index in patients with rheumatoid arthritis.

Authors:  A Häkkinen; H Kautiainen; P Hannonen; J Ylinen; M Arkela-Kautiainen; T Sokka
Journal:  Ann Rheum Dis       Date:  2004-05-06       Impact factor: 19.103

Review 9.  Pain in rheumatoid arthritis.

Authors:  David A Walsh; Daniel F McWilliams
Journal:  Curr Pain Headache Rep       Date:  2012-12

Review 10.  Review of health economics modelling in rheumatoid arthritis.

Authors:  Paul Emery
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.